Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-104

I personally think the SP is being manipulated. When the primate results were released last year, the SP went up 120% on the NASDAQ. Now, we have fantastic irrefutable results in humans, and the SP goes down. As annoying as it is, I, for one, am staying the course. I would've been super concerned if the results were either inconclusive or negative. The fact that we had a positive result with long-term sufferers leads me to believe the results in the "Double Blinded Placebo Study" will be spectacular! Why the SP isn't a reflection of this perplexes me. It's well above my paygrade. Im sure the BoD is aware of what's happening and will be working to address this behind closed doors. Their are options valued at 0.007 due to expire on the 26th of August. Im sure Stamler will want that cash to get us to January 2025. If the SP languishes at these levels, unfortunately, he won't be seeing any of that cash. Hopefully, he has a few tricks up his sleeve that may surprise us all.

Stockman